EcoDrugPlus

Presenilin-2

Ensembl ID : ENSELUG00000001236
Gene Symbol: LOC105031436
3 Cross references
206 Possible Orthologues:

Primary Amine Oxidase, Liver Isozyme

Ensembl ID : ENSELUG00000028008
Gene Symbol: LOC105027621
3 Cross references
413 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSELUG00000000791
Gene Symbol: LOC105030237
3 Cross references
250 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSELUG00000023857
Gene Symbol: PGR
1 Cross references
193 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSELUG00000004950
Gene Symbol: LOC105024400
2 Cross references
205 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSELUG00000023025
Gene Symbol: PTGDR2
4 Cross references
134 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSELUG00000013065
Gene Symbol: PTGER3
1 Cross references
197 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype

Ensembl ID : ENSELUG00000024325
Gene Symbol: LOC105012168
3 Cross references
171 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype

Ensembl ID : ENSELUG00000010295
Gene Symbol: LOC105013447
3 Cross references
163 Possible Orthologues:

Prostaglandin E2 Receptor Ep2 Subtype

Ensembl ID : ENSELUG00000015947
Gene Symbol: LOC105023270
3 Cross references
203 Possible Orthologues:

Prostaglandin E2 Receptor Ep2 Subtype

Ensembl ID : ENSELUG00000033286
Gene Symbol: LOC105017572
3 Cross references
172 Possible Orthologues:

Prostaglandin E2 Receptor Ep4 Subtype

Ensembl ID : ENSELUG00000002394
Gene Symbol: LOC105014086
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).